Reduced P53 staining in actinic keratosis is associated with squamous cell carcinoma: A preliminary study

Indian Journal of Dermatology

Volumn 58, Issue 4, 2013, Pages 325-

  Neto Pimentel, D R ^a   Alchorne, M M A ^a   Michalany, N S ^a   Abreu, M A M M ^a   Borra, R C ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Actinic keratosis; Histopathology; Immunohistochemical; P53; Squamous cell carcinoma

Indexed keywords

PROTEIN P53;

ACTINIC KERATOSIS; AGED; ARTICLE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ELASTOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

EID: 84880279749     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.113935     Document Type: Article

References (49)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 1994;30:774-8.
2. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994;372:773-6.
3. Hurwitz RM, Monger LE. Solar keratosis: An evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg 1995;21:184.
4. Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis-an update. Br J Dermatol 2007;157(Suppl 2):18-20.
5. Vatve M, Ortonne JP, Birch-Machin MA, Gupta G. Management of field change in actinic keratosis. Br J Dermatol 2007;157(Suppl 2):21-4.
6. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
7. Berhane T, Halliday GM, Cooke B, Barnetson RS. Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol 2002;146:810-15.
8. Queille S, Luron L, Spatz A, Avril MF, Ribrag V, Duvillard P, et al. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene. Carcinogenesis 2007;28:724-31.
9. Leffell DJ. The scientific basis of skin cancer. J Am Acad Dermatol 2000;42:18-22.
10. McGregor JM, Yu CC, Dublin EA, Levison DA, MacDonald DM. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer. Br J Dermatol 1992;127:463-9.
11. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 1993;90:4216-20.
12. LeBoit PE, Burg G, Weedon D. World health organization classification tumours. Pathology and genetics of skin tumors. Lyon: IARC Press; 2006
13. Stewart J, 3rd, Bevans-Wilkins K, Bhattacharya A, Ye C, Miyazaki K, Kurtycz DF. Virtual microscopy: An educator's tool for the enhancement of cytotechnology students' locator skills. Diagn Cytopathol 2008;36:363-8.
14. Yagi Y, Gilbertson JR. A relationship between slide quality and image quality in whole slide imaging (WSI). Diagn Pathol 2008;3(Suppl 1):S12.
15. De Araujo VC, Loyola AM, Pinto Junior DD, Borra RC, De Araujo NS. p53 In biopsies of oral squamous cell carcinoma. A comparative study with a malignancy grading system. Oral Oncol 1997;33:5-9.
16. Neto Pimentel DR, Michalany N, Alchorne M, Abreu M, Borra RC, Weckx L. Actinic cheilitis: Histopathology and p53. J Cutan Pathol 2006;33:539-44.
17. Hall PA, Lane DP. p53 in tumour pathology: Can we trust immunohistochemistry? Revisited! J Pathol 1994;172:1-4.
18. Ackerman AB, Mones J. Squamous-cell carcinoma in situ is a fiction! J Cutan Pathol 2009;36:74-6.
19. Callen JP, Bickers DR, Moy RL. Actinic keratoses. J Am Acad Dermatol 1997;36:650-3.
20. Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000;42:8-10.
21. Sim CS, Slater S, McKee PH. Mutant p53 expression in solar keratosis: An immunohistochemical study. J Cutan Pathol 1992;19:302-8.
22. Rossi R, Mori M, Lotti T. Actinic keratosis. Int J Dermatol 2007;46:895-904.
23. Girod SC, Pfeiffer P, Ries J, Pape HD. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1998;36:252-60.
24. Nagano T, Ueda M, Ichihashi M. Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Arch Dermatol 1993;129:1157-61.
25. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989;57:1083-93.
26. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-6.
27. Rehman I, Quinn AG, Healy E, Rees JL. High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease. Lancet 1994;344:788-9.
28. Rehman I, Takata M, Wu YY, Rees JL. Genetic change in actinic keratoses. Oncogene 1996;12:2483-90.
29. McNutt NS, Saenz-Santamaria C, Volkenandt M, Shea CR, Albino AP. Abnormalities of p53 protein expression in cutaneous disorders. Arch Dermatol 1994;130:225-32.
30. Ro YS, Cooper PN, Lee JA, Quinn AG, Harrison D, Lane D, et al. p53 protein expression in benign and malignant skin tumours. Br J Dermatol 1993;128:237-41.
31. Giglia-Mari G, Sarasin A. TP53 mutations in human skin cancers. Hum Mutat 2003;21:217-28.
32. Einspahr JG, Alberts DS, Warneke JA, Bozzo P, Basye J, Grogan TM, et al. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis. Neoplasia 1999;1:468-75.
33. Soufir N, Moles JP, Vilmer C, Moch C, Verola O, Rivet J, et al. P16 UV mutations in human skin epithelial tumors. Oncogene 1999;18:5477-81.
34. Nindl I, Gottschling M, Krawtchenko N, Lehmann MD, Rowert-Huber J, Eberle J, et al. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis. Br J Dermatol 2007;156(Suppl 3):34-9.
35. McGregor JM, Harwood CA, Brooks L, Fisher SA, Kelly DA, O'Nions J, et al. Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J Invest Dermatol 2002;119:84-90.
36. Ganguli G, Abecassis J, Wasylyk B. MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis. EMBO J 2000;19:5135-47.
37. Lu S, Tiekso J, Hietanen S, Syrjanen K, Havu VK, Syrjanen S. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement. Acta Derm Venereol 1999;79:268-73.
38. Kvlividze O, Gogiashvili L, Burkadze G. The characteristics of human papillomavirus expression and cell proliferation in actinic keratosis and Bowen's disease of the skin. Georgian Med News 2006;136:108-12.
39. Mitsuishi T, Kawana S, Kato T, Kawashima M. Human papillomavirus infection in actinic keratosis and bowen's disease: Comparative study with expression of cell-cycle regulatory proteins p21(Waf1/Cip1), p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions. Hum Pathol 2003;34:886-92.
40. Brash DE. Sunlight and the onset of skin cancer. Trends Genet 1997;13:410-14.
41. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991;88:10124-8.
42. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer res 1991;51:6304-11.
43. Shaw PH. The role of p53 in cell cycle regulation. Pathol Res Pract 1996;192:669-75.
44. Batinac T, Zamolo G, Jonjic N, Gruber F, Petrovecki M. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases. Tumori 2004;90:120-7.
45. Kumar MG, Spandau DF. p53-binding proteins in squamous cell carcinoma and normal human keratinocytes. Cell Growth Differ 1995;6:1601-8.
46. Jiang W, Ananthaswamy HN, Muller HK, Kripke ML. p53 protects against skin cancer induction by UV-B radiation. Oncogene 1999;18:4247-53.
47. Ren ZP, Ahmadian A, Ponten F, Nister M, Berg C, Lundeberg J, et al. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. Am J Pathol 1997;150:1791-803.
48. Ren ZP, Ponten F, Nister M, Ponten J. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis. Int J Cancer 1996;69:174-9.
49. Barzilai A, Lyakhovitsky A, Trau H, Fogel M, Huszar M. Expression of p53 in the evolution of squamous cell carcinoma: Correlation with the histology of the lesion. J Am Acad Dermatol 2007;57:669-76.